BlackRock Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $2.02M | Buy |
10,972
+6,393
| +140% | +$1.18M | ﹤0.01% | 1453 |
|
2016
Q3 | $1.18M | Sell |
4,579
-32,924
| -88% | -$8.48M | ﹤0.01% | 1688 |
|
2016
Q2 | $8.01M | Sell |
37,503
-118,053
| -76% | -$25.2M | 0.01% | 897 |
|
2016
Q1 | $32.1M | Sell |
155,556
-589
| -0.4% | -$121K | 0.03% | 404 |
|
2015
Q4 | $39.5M | Buy |
156,145
+3,006
| +2% | +$760K | 0.04% | 360 |
|
2015
Q3 | $25.2M | Buy |
153,139
+65,790
| +75% | +$10.8M | 0.03% | 459 |
|
2015
Q2 | $16.4M | Buy |
87,349
+81,932
| +1,512% | +$15.4M | 0.02% | 589 |
|
2015
Q1 | $894K | Buy |
5,417
+796
| +17% | +$131K | ﹤0.01% | 1605 |
|
2014
Q4 | $1.07M | Sell |
4,621
-213
| -4% | -$49.5K | ﹤0.01% | 1422 |
|
2014
Q3 | $875K | Sell |
4,834
-92
| -2% | -$16.7K | ﹤0.01% | 1491 |
|
2014
Q2 | $947K | Sell |
4,926
-8,726
| -64% | -$1.68M | ﹤0.01% | 1505 |
|
2014
Q1 | $2.48M | Buy |
13,652
+8,652
| +173% | +$1.57M | ﹤0.01% | 1109 |
|
2013
Q4 | $851K | Buy |
5,000
+364
| +8% | +$62K | ﹤0.01% | 1600 |
|
2013
Q3 | $726K | Buy |
4,636
+11
| +0.2% | +$1.72K | ﹤0.01% | 1624 |
|
2013
Q2 | $801K | Buy |
+4,625
| New | +$801K | ﹤0.01% | 1494 |
|